Advertisement
Screener

PROFUSA, INC. (PFSA) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

PROFUSA, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities

PROFUSA, INC. (PFSA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$3.05 million for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-05-01.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-05-01

  • PROFUSA, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $49.00K.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month
2025-12-31$49.00K
derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01
-$3.05M
S-1/A · filed 2026-05-01
2025-09-30-$3.10M
10-Q · filed 2025-11-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tenon Medical, Inc. (TNON)United States$0.002B
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
NEXGEL, INC. (NXGL)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B